<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (CAPS) is a severe form of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>It frequently leads to multiorgan failure with an approximate mortality rate of 50% </plain></SENT>
<SENT sid="2" pm="."><plain>The heart is involved in about 50% of the patients with CAPS </plain></SENT>
<SENT sid="3" pm="."><plain>We report two cases with CAPS and severe heart manifestations, documented by echocardiography </plain></SENT>
<SENT sid="4" pm="."><plain>Both women show regression of the valvular regurgitation under treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Valve replacement therapy was no longer necessary </plain></SENT>
<SENT sid="6" pm="."><plain>In earlier studies and case reports, cardiac valve involvement had been characterised by valve thickening and vegetations </plain></SENT>
<SENT sid="7" pm="."><plain>We suppose that (sometimes reversible) microvascular disturbances lead to valvular regurgitation via <z:e sem="disease" ids="C0149957" disease_type="Disease or Syndrome" abbrv="">papillary muscle dysfunction</z:e> and <z:e sem="disease" ids="C0206146" disease_type="Disease or Syndrome" abbrv="">myocardial stunning</z:e> </plain></SENT>
</text></document>